Correlation of BASDAI and BASFI with Clinical Features and Treatment in Chinese Patients with Ankylosing spondylitis

Gin-Jeu Lee, Yu-Sheng Chang, Chang-Youh Tsai, Chung-Tei Chou

Research output: Contribution to journalArticle

Abstract

Objective: To understand the relationship between disease activity or patient functional ability with different clinical parameters (e.g. age, gender, age at onset, disease duration) in our ankylosing spondylitis (AS) patients in Taiwan.Methods: Chinese version of Bath ankylosing spondylitis disease activity index (BASDAI) and Bath ankylosing spondylitis functional index (BASFI) was recently developed and validated by our AS Study Group. We enrolled 344 AS patients and analyzed their demographic and clinical characteristics, sulfasalazine and non-steroidal anti-inflammatory drugs (NSAIDs) use, and clinical outcome by using the Chinese version of BASDAI and BASFI.Results: The 344 AS patients were predominantly male (255) (M:F = 2.9:1) and Taiwanese (69.3%). Hakka and Mainlander ethnicity was 13.2% and 12.4%, respectively. Mean age in the study was 36.2 (M ± SD: 36.2 ± 11.95). Although the mean age at onset was 24.98, 35% of patients had onset of AS before 16 yrs. Average BASDAI score in AS patients was 3.2(range 0-8.5), and BASFI 2.55 (range 0-9.32). Uveitis was present in 29.9% patients and peripheral arthritis developed in 66.1% AS patients. Many patients (47.1%) reported that their family relatives also had AS. Correlation analysis between clinical features and BASDAI showed a significant correlation only between peripheral arthritis and BASDAI (p<0.0001). However, age, age above 35 or below 35 or different age distribution, disease duration, peripheral arthritis and NSAID use, showed a significant correlation with BASFI.Conclusion: The presence of peripheral arthritis can significantly influence both BASDAI and BASFI. The old age, longer disease duration and continuous treatment with NSAIDs was associated with a higher score in BASFI but not BASDAI. Early diagnosis and adequate management may prevent AS patients from later functional impairment.
Original languageEnglish
Pages (from-to)49-55
Number of pages7
JournalFormosan Journal of Rheumatology
Volume26
Issue number1&2
DOIs
Publication statusPublished - 2012

Fingerprint

Ankylosing Spondylitis
Baths
Therapeutics
Arthritis
Anti-Inflammatory Agents
Age of Onset
Pharmaceutical Preparations
Sulfasalazine

Keywords

  • Ankylosing spondylitis
  • Bath ankylosing spondylitis disease activity index (BASDAI) and Bath ankylosing spondylitis functional index (BASFI)
  • clinical features
  • treatment

Cite this

Correlation of BASDAI and BASFI with Clinical Features and Treatment in Chinese Patients with Ankylosing spondylitis. / Lee, Gin-Jeu; Chang, Yu-Sheng; Tsai, Chang-Youh; Chou, Chung-Tei.

In: Formosan Journal of Rheumatology, Vol. 26, No. 1&2, 2012, p. 49-55.

Research output: Contribution to journalArticle

@article{75b2e88a48a44eefaa85e593fd7df6cd,
title = "Correlation of BASDAI and BASFI with Clinical Features and Treatment in Chinese Patients with Ankylosing spondylitis",
abstract = "Objective: To understand the relationship between disease activity or patient functional ability with different clinical parameters (e.g. age, gender, age at onset, disease duration) in our ankylosing spondylitis (AS) patients in Taiwan.Methods: Chinese version of Bath ankylosing spondylitis disease activity index (BASDAI) and Bath ankylosing spondylitis functional index (BASFI) was recently developed and validated by our AS Study Group. We enrolled 344 AS patients and analyzed their demographic and clinical characteristics, sulfasalazine and non-steroidal anti-inflammatory drugs (NSAIDs) use, and clinical outcome by using the Chinese version of BASDAI and BASFI.Results: The 344 AS patients were predominantly male (255) (M:F = 2.9:1) and Taiwanese (69.3{\%}). Hakka and Mainlander ethnicity was 13.2{\%} and 12.4{\%}, respectively. Mean age in the study was 36.2 (M ± SD: 36.2 ± 11.95). Although the mean age at onset was 24.98, 35{\%} of patients had onset of AS before 16 yrs. Average BASDAI score in AS patients was 3.2(range 0-8.5), and BASFI 2.55 (range 0-9.32). Uveitis was present in 29.9{\%} patients and peripheral arthritis developed in 66.1{\%} AS patients. Many patients (47.1{\%}) reported that their family relatives also had AS. Correlation analysis between clinical features and BASDAI showed a significant correlation only between peripheral arthritis and BASDAI (p<0.0001). However, age, age above 35 or below 35 or different age distribution, disease duration, peripheral arthritis and NSAID use, showed a significant correlation with BASFI.Conclusion: The presence of peripheral arthritis can significantly influence both BASDAI and BASFI. The old age, longer disease duration and continuous treatment with NSAIDs was associated with a higher score in BASFI but not BASDAI. Early diagnosis and adequate management may prevent AS patients from later functional impairment.",
keywords = "Ankylosing spondylitis, Bath ankylosing spondylitis disease activity index (BASDAI) and Bath ankylosing spondylitis functional index (BASFI), clinical features, treatment, 僵直性脊椎炎, 僵直性脊椎炎疾病活動指數, 僵直性脊椎炎功能指數, 臨床表現, 治療",
author = "Gin-Jeu Lee and Yu-Sheng Chang and Chang-Youh Tsai and Chung-Tei Chou",
year = "2012",
doi = "10.6313/FJR.2012.26",
language = "English",
volume = "26",
pages = "49--55",
journal = "Formosan Journal of Rheumatology",
issn = "2075-0374",
publisher = "中華民國風濕病醫學會",
number = "1&2",

}

TY - JOUR

T1 - Correlation of BASDAI and BASFI with Clinical Features and Treatment in Chinese Patients with Ankylosing spondylitis

AU - Lee, Gin-Jeu

AU - Chang, Yu-Sheng

AU - Tsai, Chang-Youh

AU - Chou, Chung-Tei

PY - 2012

Y1 - 2012

N2 - Objective: To understand the relationship between disease activity or patient functional ability with different clinical parameters (e.g. age, gender, age at onset, disease duration) in our ankylosing spondylitis (AS) patients in Taiwan.Methods: Chinese version of Bath ankylosing spondylitis disease activity index (BASDAI) and Bath ankylosing spondylitis functional index (BASFI) was recently developed and validated by our AS Study Group. We enrolled 344 AS patients and analyzed their demographic and clinical characteristics, sulfasalazine and non-steroidal anti-inflammatory drugs (NSAIDs) use, and clinical outcome by using the Chinese version of BASDAI and BASFI.Results: The 344 AS patients were predominantly male (255) (M:F = 2.9:1) and Taiwanese (69.3%). Hakka and Mainlander ethnicity was 13.2% and 12.4%, respectively. Mean age in the study was 36.2 (M ± SD: 36.2 ± 11.95). Although the mean age at onset was 24.98, 35% of patients had onset of AS before 16 yrs. Average BASDAI score in AS patients was 3.2(range 0-8.5), and BASFI 2.55 (range 0-9.32). Uveitis was present in 29.9% patients and peripheral arthritis developed in 66.1% AS patients. Many patients (47.1%) reported that their family relatives also had AS. Correlation analysis between clinical features and BASDAI showed a significant correlation only between peripheral arthritis and BASDAI (p<0.0001). However, age, age above 35 or below 35 or different age distribution, disease duration, peripheral arthritis and NSAID use, showed a significant correlation with BASFI.Conclusion: The presence of peripheral arthritis can significantly influence both BASDAI and BASFI. The old age, longer disease duration and continuous treatment with NSAIDs was associated with a higher score in BASFI but not BASDAI. Early diagnosis and adequate management may prevent AS patients from later functional impairment.

AB - Objective: To understand the relationship between disease activity or patient functional ability with different clinical parameters (e.g. age, gender, age at onset, disease duration) in our ankylosing spondylitis (AS) patients in Taiwan.Methods: Chinese version of Bath ankylosing spondylitis disease activity index (BASDAI) and Bath ankylosing spondylitis functional index (BASFI) was recently developed and validated by our AS Study Group. We enrolled 344 AS patients and analyzed their demographic and clinical characteristics, sulfasalazine and non-steroidal anti-inflammatory drugs (NSAIDs) use, and clinical outcome by using the Chinese version of BASDAI and BASFI.Results: The 344 AS patients were predominantly male (255) (M:F = 2.9:1) and Taiwanese (69.3%). Hakka and Mainlander ethnicity was 13.2% and 12.4%, respectively. Mean age in the study was 36.2 (M ± SD: 36.2 ± 11.95). Although the mean age at onset was 24.98, 35% of patients had onset of AS before 16 yrs. Average BASDAI score in AS patients was 3.2(range 0-8.5), and BASFI 2.55 (range 0-9.32). Uveitis was present in 29.9% patients and peripheral arthritis developed in 66.1% AS patients. Many patients (47.1%) reported that their family relatives also had AS. Correlation analysis between clinical features and BASDAI showed a significant correlation only between peripheral arthritis and BASDAI (p<0.0001). However, age, age above 35 or below 35 or different age distribution, disease duration, peripheral arthritis and NSAID use, showed a significant correlation with BASFI.Conclusion: The presence of peripheral arthritis can significantly influence both BASDAI and BASFI. The old age, longer disease duration and continuous treatment with NSAIDs was associated with a higher score in BASFI but not BASDAI. Early diagnosis and adequate management may prevent AS patients from later functional impairment.

KW - Ankylosing spondylitis

KW - Bath ankylosing spondylitis disease activity index (BASDAI) and Bath ankylosing spondylitis functional index (BASFI)

KW - clinical features

KW - treatment

KW - 僵直性脊椎炎

KW - 僵直性脊椎炎疾病活動指數

KW - 僵直性脊椎炎功能指數

KW - 臨床表現

KW - 治療

U2 - 10.6313/FJR.2012.26

DO - 10.6313/FJR.2012.26

M3 - Article

VL - 26

SP - 49

EP - 55

JO - Formosan Journal of Rheumatology

JF - Formosan Journal of Rheumatology

SN - 2075-0374

IS - 1&2

ER -